Skip to main content
Clinical Trials/NCT02024165
NCT02024165
Completed
Not Applicable

Electrode-Based Sensor for Non-Invasive Fetal Heart Rate Monitoring With Improved Reliability

OBMedical Company1 site in 1 country71 target enrollmentNovember 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Laboring Women With Ultrasound and FSE Monitoring
Sponsor
OBMedical Company
Enrollment
71
Locations
1
Primary Endpoint
Fetal Heart Rate Interpretability
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The specific goal of the proposed research is to develop a reliable, non-invasive fetal and maternal heart rate and contraction monitor that is unaffected by obesity and requires less nursing intervention than the tocodynamometer and Doppler ultrasound.

Detailed Description

The majority of obstetric deliveries in the US undergo electronic monitoring and continuous uterine activity and fetal heart rate (FHR) monitoring is the standard of care. Typically, external transducers are employed, the reliability of which depends on their proper positioning, which may be disturbed by patient or fetal movement. The tocodynamometer (strain gauge, toco for short) provides frequency and timing of contractions, but requires transmission of tension from the uterus to the sensor. Fetal heart rate is acquired with an external Doppler ultrasound transducer. The reliability of this monitor depends on the ability to obtain a window to the fetal heart. In some patients, particularly the obese, the toco and ultrasound may fail to monitor consistently. In others both transducers require frequent repositioning by the nursing staff, and the Doppler may erroneously report maternal heart rate instead of fetal. The alternative uterine activity monitor is an intrauterine pressure catheter (IUPC), which is placed through the cervical os in the adequately dilated patient with ruptured membranes. While this monitor usually provides a more reliable signal than the toco, as well as quantitative information regarding intrauterine pressure, it is invasive and there is an increased risk of infection. The alternative FHR monitor is via fetal scalp electrode (FSE), which is applied transvaginally to the fetal presenting part, also requiring adequate cervical dilation and ruptured membranes. While the FSE usually provides a more reliable signal, it is similarly invasive and increases risk of infection. Maternal obesity (defined as BMI at presentation ≥ 30) is an ever-increasing problem in the US, and is even more prominent in the obstetric suite. Meanwhile, obese women have an increased risk for labor problems, infections and other complications. Noninvasive labor monitoring, while preferable to reduce the infection risk, is particularly unreliable in this population.

Registry
clinicaltrials.gov
Start Date
November 2013
End Date
April 2014
Last Updated
10 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Parturients presenting to Labor \& Delivery for labor at term (\>36 weeks completed gestation)
  • Single viable fetus in cephalic presentation
  • With FSE or IUPC for obstetric indications

Exclusion Criteria

  • Multi fetal gestation
  • Contraindication to FSE or IUPC placement
  • Insufficient abdominal space for all required sensors

Outcomes

Primary Outcomes

Fetal Heart Rate Interpretability

Time Frame: 2 hours

The Fetal Heart Rate (or FHR) of the electrode sensor will be compared to the FHR of the ultrasound when both are compared to the FSE. Percentage of time that signals are interpretable will be compared between devices

Study Sites (1)

Loading locations...

Similar Trials